These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6786926)

  • 21. Studies on the selective lysis and purification of Trypanosoma cruzi.
    Nogueira N; Bianco C; Cohn Z
    J Exp Med; 1975 Jul; 142(1):224-9. PubMed ID: 807672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An explanation for the inefficiency of guinea pig complement in the cytolysis of sheep erythrocytes or rat mast cells sensitized with rabbit antiserum: a double block.
    Kempf RA; Gigli I; Austen KF
    Transplant Proc; 1969 Mar; 1(1):626-8. PubMed ID: 4109231
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparison of the effects of divalent ion chelating agents on complement-mediated hemolysis in rabbit and human serum.
    Marney SR; Des Prez RM
    J Immunol; 1969 Nov; 103(5):1044-9. PubMed ID: 4981793
    [No Abstract]   [Full Text] [Related]  

  • 24. Complement-fixing IgG1 constitutes a new subclass of mouse IgG.
    Ey PL; Prowse SJ; Jenkin CR
    Nature; 1979 Oct; 281(5731):492-3. PubMed ID: 114859
    [No Abstract]   [Full Text] [Related]  

  • 25. Sheep serum complement sensitisation of sheep erythrocyte-rabbit antibody complexes for haemolysis by guinea-pig complement plus EDTA or Mg2+-EGTA.
    Jonas W; Stankiewicz M
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):451-60. PubMed ID: 3099725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crytobia catostomi: incubation in plasma of susceptible and refractory fishes.
    Bower SM; Woo PT
    Exp Parasitol; 1977 Oct; 43(1):63-8. PubMed ID: 408171
    [No Abstract]   [Full Text] [Related]  

  • 27. Canine hemolytic complement: optimal conditions for its titration.
    Barta O; Barta V
    Am J Vet Res; 1973 May; 34(5):653-7. PubMed ID: 4634064
    [No Abstract]   [Full Text] [Related]  

  • 28. Phylogeny and function of the complement system.
    Gigli I; Austen KF
    Annu Rev Microbiol; 1971; 25():309-32. PubMed ID: 5005029
    [No Abstract]   [Full Text] [Related]  

  • 29. Schistosoma mansoni: the role of the complement C3-activating system in the cercaricidal action of normal serum.
    Machado AJ; Gazzinelli G; Pellegrino J; Dias de Silva W
    Exp Parasitol; 1975 Aug; 38(1):20-9. PubMed ID: 807484
    [No Abstract]   [Full Text] [Related]  

  • 30. Activation of the classic and alternate complement pathways by endotoxin.
    Fine DP
    J Immunol; 1974 Feb; 112(2):763-9. PubMed ID: 4205207
    [No Abstract]   [Full Text] [Related]  

  • 31. Consumption of complement in chelated and nonchelated guinea pig serum after challenge with some viral and nonviral interferon inducers.
    Rathová V; Kocisková D; Krizanová O; Borecký L
    Acta Virol; 1976 Feb; 20(1):86-8. PubMed ID: 7949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of Plasmodium berghei-infected erythrocytes with complement.
    Schetters TP; Van Lent P; Van Zon AA; Eling WM
    J Protozool; 1985 May; 32(2):321-5. PubMed ID: 3925133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kinetics of bovine complement. II. Properties of the lytic intermediate.
    Fong JS; Muschel LH; Good RA
    J Immunol; 1971 Jul; 107(1):34-40. PubMed ID: 4997115
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function.
    Fine DP
    Infect Immun; 1977 Apr; 16(1):124-8. PubMed ID: 406201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.
    Rosenfeld SI; Packman CH; Jenkins DE; Countryman JK; Leddy JP
    J Immunol; 1980 Nov; 125(5):2063-8. PubMed ID: 6776186
    [No Abstract]   [Full Text] [Related]  

  • 36. Haemolytic assay of bovine serum complement.
    Barta O; Barta V
    J Immunol Methods; 1972 Aug; 1(4):363-74. PubMed ID: 4218251
    [No Abstract]   [Full Text] [Related]  

  • 37. Spontaneous haemolytic activity of Atlantic halibut (Hippoglossus hippoglossus L.) and sea bass (Dicentrarchus labrax) serum.
    Lange S; Magnadóttir B
    Comp Biochem Physiol B Biochem Mol Biol; 2003 Sep; 136(1):99-106. PubMed ID: 12941643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconstruction of anti-leprosy drug depleted complement haemolytic activity by addition of zymosan-treated sera (a source of C142) and CratEDTA (a source of C3-C9).
    Kashyap A; Saha K; Sehgal VN
    Int J Immunopharmacol; 1992 Nov; 14(8):1409-14. PubMed ID: 1464472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteins.
    Nydegger UE; Fearon DT; Austen KF
    J Immunol; 1978 Apr; 120(4):1404-8. PubMed ID: 565382
    [No Abstract]   [Full Text] [Related]  

  • 40. Immune haemolysis: reaction of the terminal complement component.
    Götze O; Haupt I; Fischer H
    Nature; 1968 Mar; 217(5134):1165-7. PubMed ID: 4966850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.